Back
Arcturus Therapeutics Holdings Stock Predictions
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Buy
57
ARCT
Arcturus Therapeutics Holdings
Last Price:
24.73
Seasonality Move:
-7.1%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Arcturus Therapeutics Holdings Stock Forecast
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 16.8% based on the past 11 years of stock performance.
- Arcturus Therapeutics Holdings has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
-
Is Arcturus Therapeutics Holdings Stock Undervalued?
The current Arcturus Therapeutics Holdings [ARCT] share price is $25.48. The Score for ARCT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal. - ARCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings Stock Go Up Next Year?
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 16.8% based on the past 11 years of stock performance.
Arcturus Therapeutics Holdings Stock Rating
Buy
57
Arcturus Therapeutics Holdings (ARCT)
is a Buy
Is Arcturus Therapeutics Holdings overpriced?
- Arcturus Therapeutics Holdings has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Arcturus Therapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
45.00
52-Week Low:
17.52
Prediction Charts
Market Cap:
689.04M
Price in USD:
25.48
Volume:
400.59K
Beta:
2.52
Technical Analysis
SMA50:
21.02
SMA100:
24.95
SMA200:
29.03
52-Wk Change:
-0.7%
Stock Predictions
-
Is Arcturus Therapeutics Holdings stock public?
Yes, Arcturus Therapeutics Holdings is a publicly traded company. -
What is the Arcturus Therapeutics Holdings stock quote today?
The Arcturus Therapeutics Holdings stock price is 25.48 USD today. -
How to buy Arcturus Therapeutics Holdings stock online?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-13 | 20.22 | 20.75 | 20.87 | 19.97 |
| Sep-16 | 20.96 | 20.61 | 21.41 | 20.10 |
| Sep-17 | 21.02 | 21.01 | 21.99 | 20.62 |
| Sep-18 | 20.80 | 20.55 | 21.55 | 20.05 |
| Sep-19 | 21.23 | 21.05 | 21.70 | 20.94 |
| Sep-20 | 20.88 | 20.61 | 21.50 | 20.39 |
| Sep-23 | 20.61 | 21.15 | 21.66 | 20.50 |
| Sep-24 | 21.16 | 21.74 | 21.96 | 21.12 |
| Sep-25 | 21.73 | 21.31 | 21.96 | 20.89 |
| Sep-26 | 21.72 | 21.77 | 21.79 | 21.10 |
| Sep-27 | 22.17 | 22.03 | 22.37 | 21.74 |
| Sep-30 | 21.69 | 23.19 | 23.55 | 21.55 |
| Oct-1 | 22.96 | 25.25 | 25.31 | 21.99 |
| Oct-2 | 25.31 | 25.48 | 25.88 | 24.57 |
Arcturus Therapeutics Holdings Earnings
Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings Forecast Revenue Growth
Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.